Special Issue "Clinical Research on Glomerulonephritis"
Deadline for manuscript submissions: closed (20 November 2023) | Viewed by 2275
Interests: diabetic nephropathy; chronic kidney disease; tubulointerstitial fibrosis; dialysis; medical education
Glomerulonephritis is one of the major causes leading to end-stage kidney disease. Many advances have been made for delaying the progression of glomerulonephritis over the last decade. These include the development of efficient diagnostic tools, the implementation of patient-centered clinical trials, and the exploration of novel therapeutic regimens or agents. Despite this progress, many clinical questions remain inconclusive. We still have not critically evaluated some proposed guidelines or recommendations despite emerging evidence to challenge current paradigms and discrepant patient-preferred outcomes.
We are pleased to invite you to contribute to this Special Issue by submitting clinical research articles or reviews in glomerulonephritis investigating outcome prediction equations and exploring how to ensure early and precise diagnosis, develop better diagnostic tools or disease markers, and implement best practices. We also welcome authors to submit papers relating to clinical issues in the fields of other glomerular diseases. We look forward to receiving your contributions.
Dr. Chun-Wu Tung
Dr. Mei-Yi Wu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- glomerular disease
- nephrotic syndrome
- nephritic syndrome